Results 121 to 130 of about 2,124,017 (159)
Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation [PDF]
European Heart Journal, 2023 BACKGROUND AND AIMS The impact of sex in patients with significant tricuspid regurgitation (TR) undergoing transcatheter tricuspid valve intervention (TTVI) is unknown.
Fabien Praz +2 more
exaly +3 more sources
Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention [PDF]
JACC: Cardiovascular Interventions, 2020 OBJECTIVES The aim of this study was to assess the clinical outcome of baseline massive or torrential tricuspid regurgitation (TR) after transcatheter tricuspid valve intervention (TTVI). BACKGROUND The use of TTVI to treat symptomatic severe TR
Fabien Praz +2 more
exaly +2 more sources
Eligibility for Transcatheter Tricuspid Valve Interventions in Patients With Tricuspid Regurgitation
JACC: Cardiovascular InterventionsIt remains unclear what proportion of patients with tricuspid regurgitation (TR) are suitable candidates for transcatheter tricuspid valve intervention (TTVI) in clinical practice.The aim of this study was to ascertain the prevalence of eligibility for tricuspid transcatheter edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement ...
Miriam Silaschi +2 more
exaly +3 more sources
Imaging Needs in Novel Transcatheter Tricuspid Valve Interventions
JACC: Cardiovascular Imaging, 2018 The advent of novel transcatheter therapies for severe tricuspid regurgitation (TR) has attracted much attention. Novel 3-dimensional imaging techniques have permitted analysis of the tricuspid valve (TV) anatomy from unparalleled views and better understanding of the underlying pathophysiology of TR.
Jeroen Joost Bax +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Transcatheter Tricuspid Valve Interventions: An Emerging Field
Current Cardiology Reports, 2019This review aims to provide an updated overview and a clinical perspective on novel transcatheter tricuspid valve interventions (TTVI), highlighting potential challenges and future directions.Severe tricuspid regurgitation (TR) is a predictor of mortality.
Gheorghe, Livia +6 more
openaire +3 more sources
Transcatheter tricuspid valve intervention: state of the art
EuroIntervention, 2017The assessment and management of tricuspid valve (TV) disease have evolved substantially in recent years. Increased understanding of the long-term adverse consequences of severe tricuspid regurgitation (TR), along with continued advances in surgical and percutaneous techniques, has led to a renewed interest in the "forgotten valve".
Taramasso M, Maisano F
openaire +4 more sources
Transcatheter tricuspid valve intervention
Current Opinion in Cardiology, 2019Worldwide experience in transcatheter tricuspid valve intervention is increasing as more options become available for the treatment of severe tricuspid regurgitation. These devices can be categorized by their primary mechanism of action, including edge-to-edge leaflet devices, space occupying devices, annuloplasty devices, complete valve replacement ...
Edwin C, Ho, Geraldine, Ong, Neil P, Fam
openaire +2 more sources
Transcatheter tricuspid intervention: ready for primetime?
Heart, 2021### Learning objectives In clinical practice, tricuspid regurgitation (TR) is a common finding and can frequently be observed during routine echocardiography—as an incidental finding or as a consequence of leading left-sided heart diseases (as secondary TR (sTR)).1 Population-based data regarding the prevalence of TR are divergent—mainly due to ...
Johanna Vogelhuber +2 more
openaire +2 more sources
Transcatheter interventions for tricuspid regurgitation: MitraClip
EuroIntervention, 2016Robert, Schueler +3 more
openaire +2 more sources
Transcatheter Intervention for Management of Tricuspid Regurgitation Using TriClip
Cardiology in ReviewSevere tricuspid regurgitation (TR) is an underrated, common pathology that affects over 70 million individuals worldwide. Traditionally, TR has been managed with diuretic therapies without any significant mortality benefit. The underlying cause of TR can be primary, coming from structural issues with tricuspid valve and more commonly secondary ...
Anmol, Sharedalal +4 more
openaire +2 more sources